Ahead of next week’s returning Pharmapack Europe 2023 (February 1-2), the event’s panel of experts predict increased consolidations in 2023—driven by supply chain concerns and big pharma preferences—a relaxation of MDR deadlines, and high-viscosity delivery as the biggest area of device innovation.
The event, which is at the heart of pharma’s packaging and drug delivery devices industry, returns to the Paris Expo, Porte de Versailles (Hall 7.2) and will see 5,500 attendees and over 300 companies exploring next-generation technologies and looking ahead to debate the major industry developments and growth opportunities.




















